TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has provided an update.
Fuso Pharmaceutical Industries, Ltd. announced that there will be no revisions to its financial results forecast for the fiscal year ending March 31, 2026, despite a recent patent infringement lawsuit. The company also confirmed that there will be no changes to its dividend forecast, signaling stability in its financial outlook and commitment to shareholder returns.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange Prime Market and is known for its commitment to innovation and quality in healthcare solutions.
Average Trading Volume: 26,160
Technical Sentiment Signal: Sell
Current Market Cap: Yen18.93B
Find detailed analytics on 4538 stock on TipRanks’ Stock Analysis page.